Assessing HPV Vaccination Trends and Their Alignment with Evolving Recommendations
Otolaryngology–Head and Neck Surgery · 2026
DOI: 10.1002/ohn.70310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2026. Verfasst von Sarah E Loheide und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head & Neck Surgery, New York Presbyterian Hospital, Columbia University College of Physicians & Surgeons and Weill Corn…. Hauptthemen laut MEDLINE: Papillomavirus Vaccines, Papillomavirus Infections, Vaccination, Head and Neck Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
HPV vaccination recommendations have expanded to include both sexes and a broadened age range since approval in 2006. These changes and increasing HPV‐related head and neck cancer rates support vaccination of older and male patients, necessitating changes in HPV education. We aim to analyze vaccination trends and to identify opportunities for increasing awareness. Study Design Cross‐sectional study analyzing vaccination trends between 2007 and 2023.
Setting
US hospitals and clinics using Epic.
Methods
Using Epic Cosmos, a national database, vaccination trends for patients aged 9 to 45 were stratified by year, demographics, and administering provider specialty.
Results
19.6 million HPV vaccinations were administered between 2007 and 2023. The inclusion of males aged 9 to 21 in the recommendations beginning in 2009 corresponded with an 836% increase in vaccinations in this group from 2010 to 2016. Males comprised 49.9% of vaccinated patients aged 9 to 18 in 2023, a percentage that increased annually since 2010. Head and neck cancer prevention became a designated vaccine indication in 2020. Despite broadened indications, total vaccination declined by 47.1% from 2016 to 2023 in patients aged 9 to 26. In 2012, 74.8% of vaccinations were administered in pediatrics and 18.3% in family medicine. In 2023, pediatrics administered 46.6%, family medicine 33.3%, OBGYN 7.1%, and primary care 6.8%.
Conclusion
Expanding guidelines have had inconsistent impacts on vaccination trends, as rates decreased in target populations since 2016. Males contribute equally to pediatric but not adult vaccinations. Departments administering vaccines are diversifying, though pediatrics predominates. Gendered and outdated education and marketing could contribute to disparities and discordance with guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head & Neck Surgery, New York Presbyterian Hospital, Columbia University College of Physicians & Surgeons and Weill Cornell Medical College, New York University, New York, New York, USA.
- Department of Otolaryngology-Head & Neck Surgery, New York University Grossman School of Medicine, New York, New York, USA.
ORCID-Profile: Lindsey E Moses
Zitieren
APA
Loheide, S. E., Lee, B. M., Taufique, Z. M., & Moses, L. E. (2026). Assessing HPV Vaccination Trends and Their Alignment with Evolving Recommendations. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70310
Vancouver
Loheide SE, Lee BM, Taufique ZM, Moses LE. Assessing HPV Vaccination Trends and Their Alignment with Evolving Recommendations. Otolaryngology–Head and Neck Surgery. 2026. doi:10.1002/ohn.70310
BibTeX
@article{Loheide2026,
author = {Loheide, Sarah E and Lee, Braydon M and Taufique, Zahrah M and Moses, Lindsey E},
title = {Assessing HPV Vaccination Trends and Their Alignment with Evolving Recommendations},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2026},
doi = {10.1002/ohn.70310}
}
EUVIMED